Lawmakers Dismiss McKinsey ’s Apology on Opioid Crisis as ‘Empty’

The consulting firm ’s top executive was apologetic before Congress but denied that advising both opioid manufacturers and their federal regulator posed a conflict of interest.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Consultants Opioids and Opiates Drugs (Pharmaceuticals) United States Politics and Government Pain-Relieving Drugs OxyContin (Drug) Drug Abuse and Traffic Food and Drug Administration McKinsey & Purdue Pharma Johnson Sternfels, Bob Source Type: news